Better transparency needed on medical journals' competing interests

October 26, 2010, Public Library of Science

Journals need to develop policies to handle the inevitable competing interests that arise when they publish papers that may bring them reprint revenue or increase their impact factors. This is the conclusion of a research article by Andreas Lundh and colleagues from the Nordic Cochrane Centre published in this weeks PLoS Medicine. An accompanying perspective by Harvey Marcovitch, ex-chair of the Committee on Publication Ethics (COPE), and an editorial from the PLoS Medicine Editors discusses this issue further, concluding that journals should apply the same degree of transparency that they require from authors, to themselves.

The article examined randomized clinical trials published in six general medical journals (not including but including (NEJM), the British Medical (BMJ), The Lancet, , , and JAMA,) over two time periods, 1996-97 and 2005-06, and assessed which of the trials were supported wholly, partly, or not at all by industry. They then used the online academic citation index Web of Science to calculate an approximate impact factor for each journal for 1998 and 2007 and calculated the effect of the published RCTs on the impact factor.

The proportion of RCTs with sole industry support varied between journals. 32% of the RCTs published in the NEJM during both two-year periods had industry support whereas only 7% of the RCTs published in the BMJ in 2005-06 had industry support. Industry-supported trials were more frequently cited than RCTs with other types of support; omitting industry-supported RCTs from impact factor calculations decreased all the approximate journal impact factors. For example, omitting all RCTs with industry or mixed support decreased the 2007 BMJ and NEJM impact factors by 1% and 15%, respectively.

Finally, the researchers asked the Editor of each journal about journal income from industry sources. For the BMJ and the Lancet, the only journals that provided this information directly, income from reprint sales was 3% and 41%, respectively, of total income in 2005-06.

The authors conclude that "journals [should] abide by the same standards related to conflicts of interest, which they rightly require from their authors, and that the sources and the amount of income are disclosed to improve transparency." Commenting on the article, Harvey Marcovitch agrees, saying "Journal editors have expended much time and effort in teasing out how to handle authors' and reviewers' competing interests. They need now to concentrate on their own and those of their employers".

In the accompanying editorial "Increased Responsibility and Transparency in an Era of Increased Visibility" the PLoS Medicine Editors, who have posted their own journal's income on the competing interest page of the journal, conclude that "The internet has spurred an intellectual revolution in the dissemination of medical information. Journals have thus far been accepted as one of the most trusted sources of information. It's clear, however, that in order to maintain that trust, journals and editors need to continue to consider all the pressures that can arise in publishing and put in place robust, transparent procedures for handling all the potential conflicts that can arise, whether they are those of authors, editors, or the journals themselves.''

More information: Lundh A, Barbateskovic M, Hrobjartsson A, Gøtzsche PC (2010) Conflicts of Interest at Medical Journals: The Influence of Industry-Supported Randomised Trials on Journal Impact Factors and Revenue – Cohort Study. PLoS Med 7(10): e1000354. doi:10.1371/journal.pmed.1000354

Related Stories

Recommended for you

Best of Last Year—The top Medical Xpress articles of 2017

December 20, 2017
It was a good year for medical research as a team at the German center for Neurodegenerative Diseases, Magdeburg, found that dancing can reverse the signs of aging in the brain. Any exercise helps, the team found, but dancing ...

Pickled in 'cognac', Chopin's heart gives up its secrets

November 26, 2017
The heart of Frederic Chopin, among the world's most cherished musical virtuosos, may finally have given up the cause of his untimely death.

Sugar industry withheld evidence of sucrose's health effects nearly 50 years ago

November 21, 2017
A U.S. sugar industry trade group appears to have pulled the plug on a study that was producing animal evidence linking sucrose to disease nearly 50 years ago, researchers argue in a paper publishing on November 21 in the ...

Female researchers pay more attention to sex and gender in medicine

November 7, 2017
When women participate in a medical research paper, that research is more likely to take into account the differences between the way men and women react to diseases and treatments, according to a new study by Stanford researchers.

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.